Davidson Kempner Capital Management »

Atai Life Sciences Nv shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Atai Life Sciences Nv (ATAI) shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Atai Life Sciences Nv

Tip: Access up to 7 years of quarterly data

All positions including Atai Life Sciences Nv held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atai Life Sciences Nv by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $1.9M 1.4M 1.36
2024-12-31 $1.3M 949k 1.33

More positions owned by Davidson Kempner Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Verona Pharma Sponsored Ads (VRNA)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Pdd Holdings Note 12/0 (Principal)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Uber Technologies Note 0.875%12/0 (Principal)
Jd.com Note 0.250% 6/0 (Principal)
Amazon (AMZN)
Arko Corp (ARKO)
Rivian Automotive Note 4.625% 3/1 (Principal)
Redfin Corp Note 0.500% 4/0 (Principal)
NVIDIA Corporation (NVDA)
Snowflake Note 10/0 (Principal)

View all positions for Davidson Kempner Capital Management

Top funds holding Atai Life Sciences Nv

UBS Group
Adage Capital Partners GP
Citadel Advisors
Ally Bridge Group
ARK Investment Management
T. Rowe Price Investment Management
Susquehanna International
Millennium Management
Pale Fire Capital SE
Marshall Wace
Moore Capital Management
ADAR1 Capital Management
Jpmorgan Chase & Co
Jane Street
Brown University

View all funds holding Atai Life Sciences Nv